Evidence map›Paper›PMID 28585815›Full record

ArticleACS infectious diseases2017

Neisseria gonorrhoeae Lytic Transglycosylases LtgA and LtgD Reduce Host Innate Immune Signaling through TLR2 and NOD2.

Kayla J Knilans, Kathleen T Hackett, James E Anderson, Chengyu Weng, Joseph P Dillard, Joseph A Duncan

Abstract readLetter
In one paragraph

Article in ACS infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. A NovelFrontiers in microbiology · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Infection and immunity · 2019
    Article
  20. AFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kayla J KnilansDepartment of Pharmacology, University of North Carolina-Chapel Hill School of Medicine , 4009 Genetic Medicine Building, 120 Mason Farm Road, Chapel Hill, North Carolina 27599-7365, United States.
Kathleen T HackettDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison School of Medicine and Public Health , 1550 Linden Drive, Madison, Wisconsin 53706, United States.
James E AndersonDivision of Infectious Diseases, Department of Medicine, University of North Carolina-Chapel Hill School of Medicine , Bioinformatics Building, 130 Mason Farm Road, Chapel Hill, North Carolina 27599-7030, United States.
Chengyu WengDepartment of Pharmacology, University of North Carolina-Chapel Hill School of Medicine , 4009 Genetic Medicine Building, 120 Mason Farm Road, Chapel Hill, North Carolina 27599-7365, United States.
Joseph P DillardDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison School of Medicine and Public Health , 1550 Linden Drive, Madison, Wisconsin 53706, United States.
Joseph A DuncanDivision of Infectious Diseases, Department of Medicine, University of North Carolina-Chapel Hill School of Medicine , Bioinformatics Building, 130 Mason Farm Road, Chapel Hill, North Carolina 27599-7030, United States.ORCID 0000-0002-4438-2018
University of North Carolina at Chapel Hill · USUniversity of Wisconsin–Madison · US

Funding

Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1995 to 2014
$24.9M
Training in Sexually Transmitted Infections and HIVT32AI007001 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SENA-SOBERANO, ARLENE C. · 1985 to 2025
$10.9M
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (ACU19AI113170 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI JERSE, ANN E. · 2014 to 2018
$6.9M
Peptidoglycan metabolism and fragment releaseR01AI097157 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI DILLARD, JOSEPH P · 2012 to 2022
$5.6M
NIAID NIH HHS R01 AI097157NIAID NIH HHS T32 AI007001NIAID NIH HHS U19 AI031496NIAID NIH HHS U19 AI113170
6 · The paper itself

Abstract

Neisseria gonorrhoeae releases anhydro peptidoglycan monomers during growth through the action of two lytic transglycosylases encoded in the N. gonorrhoeae genome, LtgA and LtgD. Because peptidoglycan and peptidoglycan components activate innate immune signaling, we hypothesized that the activity of LtgA and LtgD would influence the host responses to gonococcal infection. N. gonorrhoeae lacking LtgA and LtgD caused increased host production of inflammatory cytokines IL-1β and TNF-α. Culture supernatants from ΔltgA/ΔltgD N. gonorrhoeae contain more shed outer membrane-associated proteins and multimeric peptidoglycan fragments rather than monomers. These culture supernatants were more potent activators of host TLR2 and NOD2 signaling when compared to supernatants from the isogenic parental N. gonorrhoeae strain. Purified peptidoglycan monomers containing anhydro muramic acid produced by LtgA were poor stimulators of NOD2, whereas peptidoglycan monomers containing reducing muramic acid produced by host lysozyme were potent stimulators of NOD2. These data indicate that LtgA and LtgD reduce recognition of N. gonorrhoeae by TLR2 and NOD2.

Indexed as

Immunity, InnateBacterial ProteinsCytokinesGlycosyltransferasesHumansMuramic AcidsNeisseria gonorrhoeaeNod2 Signaling Adaptor ProteinPeptidoglycanSignal TransductionTHP-1 CellsToll-Like Receptor 2Bacterial ProteinsCytokinesGlycosyltransferasesMuramic AcidsNOD2 protein, humanNod2 Signaling Adaptor ProteinPeptidoglycanTLR2 protein, humanToll-Like Receptor 2innate immunitylysozymelytic transglycosylaseNeisseria gonorrhoeaeNOD2peptidoglycan

Identifiers

PMID28585815
PMCPMC5839173
OpenAlexW2621640523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.